Mebendazole and Cancer: A Deworming Drug Under Laboratory Investigation
Mebendazole has decades of safety data as an antiparasitic and a growing set of lab studies looking at how it affects cancer cell division. What the mechanism research suggests, and why lab findings haven't yet translated into approved use.
Full article coming soon. The complete evidence review for this topic is in progress and will be published here.